240
A. Jacobi et al. / Journal of Organometallic Chemistry 571 (1998) 231–241
Found: C, 41.91; H, 4.82; N, 13.20; P, 4.86%.
C22H30N6PF6Rh (626.39): Anal. Calc.: C, 42.18; H,
4.83; N, 13.42; P, 4.94%. MS (FAB), m/z (%) [frag.]:
yellow microcrystalline solid. m.p. 190°C (decomposi-
tion). Anal. Found: C, 49.32; H, 5.65; N, 4.10%.
C32H44N3P3F6Rh (749.56): Anal. Calc.: C, 51.28; H,
5.92; N, 5.61%. MS (FAB), m/z (%) [frag.]: 604 (100)
[{(5)Rh(COD)}+], 494 (17) [{(5)Rh}+]. 1H-NMR
(CDCl3): 0.10 (s, 3H, CqCH3), 1.73–3.09 [m, 24H,
methylen–H(COD), CH2P, CH2N, NMe2], 3.71, 4.86
[2m, 4H, Olefin–H(COD)], 4.55, 5.51 (2m, 2H, CH2pz),
5.90 (bs, 1H, CH(4)pz), 7.20–7.89 (m, 10H, aromatic
H). 13C-NMR: no spectrum obtained because of the
low solubility of 7h. 31P-NMR (CDCl3): +16.2 (d, 1P,
1JRhP=149.0 Hz), −144.2 (sept, 1P, 1JPF=712 Hz,
PF6−).
1
481 (100) [{(3)Rh(COD)}+], 373 (6) [{(3)Rh}+]. H-
NMR (CDCl3): 1.00 (s, 3H, CqCH3), 2.06–2.71 (m, 8H
methylene–H(COD), 4.27 [bs, 4H, olefin–H(COD)],
4.62 (m, 4H, CH2N), 4.75, 5.63 (2bs, 2H, CH2N), 6.41
(m, 3H, CH(4)pz), 7.54–8.38 (m, 6H, CH(3)pz,
CH(5)pz). 13C–NMR (CDCl3): 18.5 (bs, CqCH3), 31.0
[bs, Cmethylene(COD)], 41.8 (s, Cq), 60.9, 61.4 (2bs,
CH2N), 84.6, 86.9 [2bs, Colefin(COD)], 106.3, 108.7 (2s,
CH(4)pz), 132.9–140.7 (m, aromatic C, CH(5)pz,
1
CH(3)pz). 31P-NMR (CDCl3): −143.9 (sept, JPF
=
712 Hz, PF6−).
4.11. p2-(P,O)-[2,2-Bis-(diethylaminomethyl)-
3-(diphenylphosphanylmethyl)-1-propanol] rhodium
(I)p4-1,5-cyclooctadiene]hexafluorophosphate (7i)
4.9. p2-(P,N)-[2-(Diphenylphosphanylmethyl)-
2,2-bis-(pyrazol-1-yl-methyl)-1-propanol-rhodium(I)-
p4-1,5-cyclooctadiene]hexafluorophosphate (7g)
Compound 7i was prepared as described above for
7a. Starting materials: 415 mg (1 mmol) 6 ([7]b), 247 mg
(0.5 mmol) di-v-chloro-bis-(p4-1,5-cyclooctadiene)-
dirhodium(I), 190 mg (1.03 mmol) potassium hex-
afluorophosphate. Chromatographic workup (see
above) allowed the elution of 7i as a sharp yellow band
with dichloromethane/THF 1:1 which gave upon re-
moval of the solvent 650 mg (0.84 mmol, 84%) 7i as a
yellow microcrystalline solid. Recrystallisation afforded
540 mg (0.70 mmol, 70%) of 7i in the form of yellow
needles suitable for X-ray structural analysis, m.p. 120–
130°C (decomposition). Anal. Found: C, 51.09; H, 6.69;
N, 3.59; P, 7.96%. C33H51N2P2F6Rh (770.62): Anal.
Calc.: C, 51.43; H, 6.67; N, 3.64; P, 8.04%. MS (FAB),
m/z (%) [frag.]: 625 (100) [{(6)Rh(COD)}+], 513 (15)
[{(6)Rh}+], 415 (22) [(6)+]. 1H-NMR (CDCl3): 1.11
(m, 12H, CH2CH3), 2.12–3.01 [m, 22H, methylene–
H(COD), CH2P, CH2N, CH2CH3], 3.81 (s, 2H, CH2O),
5.15 [m, 4H, olefin–H(COD)], 7.54–7.70 (m, 10H,
aromatic H). 13C-NMR (CDCl3): 10.8 (s, NCH2CH3),
28.5 [bs, Cmethylene(COD)], 31.0 (m, CH2P), 33.1 (s,
CH2N), 42.0 (s, Cq), 49.0 (s, NCH2CH3), 63.7 (s,
CH2O), 72.0 (bs, CH2N), 108.2 [bs, Colefin(COD)],
129.6–133.8 (m, aromatic C). 31P-NMR (CDCl3): +
Compound 7g was prepared as described above for
7a. Starting materials: 405 mg (1 mmol) 4b ([7]b), 247
mg (0.5 mmol) di-v-chloro-bis-(p4-1,5-cyclooctadiene)-
dirhodium(I), 190 mg (1.03 mmol) potassium hex-
afluorophosphate. Chromatographic workup (see
above) gave upon removal of the solvent 620 mg (0.81
mmol, 81%) 7g as a yellow microcrystalline solid. Re-
crystallisation at 0°C afforded 420 mg (0.55 mmol,
55%) of 7g in the form of yellow crystals suitable for
X-ray structural analysis, m.p. 170°C (decomposition).
Anal. Found: C, 49.12; H, 5.15; N, 7.27; P, 7.97%.
C31H37N4OP2F6Rh (760.50): Anal. Calc.: C, 48.96; H,
4.90; N, 7.37; P, 8.15%. MS (FAB), m/z (%) [frag.]: 615
(100) [{(4b)Rh(COD)}+], 507 (21) [{(4b)Rh}+]. 1H-
NMR (CD2Cl2): 2.21–2.90 (m, 10H, methylene–
H(COD), CH2N), 3.14, 5.05 [m, 4H, olefin–H(COD)],
3.72 (m, 2H, CH2P), 4.43 (bs, OH), 5.19 (bs, 2H,
3
CH2O), 6.41 (s, 1H, JHH=2.1 Hz, CH(4)pz), 7.49–
7.97 (m, 14H, aromatic H, CH(3)pz, CH(5)pz). 13C-
NMR: no spectrum obtained because of the low
solubility of 7f. 31P-NMR (CD2Cl2): +16.9 (d, 1P,
1JRhP=147 Hz), −144.0 (sept, 1P, 1JPF=712 Hz,
PF6−).
1
1
17.7 (d, 1P, JRhP=164 Hz), −144.2 (sept, 1P, JPF
=
4.10. p2-P,N-[2-(Dimethylaminomethyl)-2-(diphenyl-
phosphanylmethyl)-2-(3,5-dimethyl-pyrazol-1-yl-
methyl)-ethan-rhodium(I)-p4-1,5-cyclooctadiene]-
hexafluorophosphate (7h)
710 Hz, PF6−).
4.12. Hydrogenation experiments
The hydrogenations were performed under the condi-
tions given in Tables 2 and 3. Final conversions were
determined by 1H-NMR. The hydrogenations of
diphenylacetylene were performed in a HR100 steel
Compound 7h was prepared as described above for
7a. Starting materials: 394 mg (1 mmol) 5 ([7]b), 247 mg
(0.5 mmol) di-v-chloro-bis-(p4-1,5-cyclooctadiene)-
dirhodium(I), 190 mg (1.03 mmol) potassium hex-
afluorophosphate. Chromatographic workup (see
above) allowed the elution of 7d as a sharp yellow band
with dichloromethane/THF 1:1 which gave upon re-
moval of the solvent 680 mg (0.90 mmol, 90%) 7h as a
laboratory
autoclave
(Berghof/Maasen
GmbH)
equipped with a manometer and inlet and outlet valves.
The solutions were prehydrogenated for 1 h at room
temperature and normal pressure. The hydrogenations
of (Z)-h-N-acetamidocinnamic acid were performed at